Jim Moody

Welcome to Jim’s CaringBridge website. We are using it to keep family and friends updated in one place. We appreciate your support, words of hope and encouragement.

Jim started a battle with prostate cancer in April 2009. A man full of life and love is determined to beat it. Maybe the determination was inherited from his beautiful Mother (who lived to be 97), the love for his family and friends or maybe it’s just all about being here to watch more OU football. Whatever is driving him to beat this cancer has created a true warrior. Jim began chemotherapy treatments in December 2017 and never missed a beat thru many different chemotherapy drugs and treatments. April 2021 his local Oncologist, Dr. Aleda Toma referred him to MD Anderson in Houston for participation in a clinical trial.  His determination raged on and he signed up! It didn't take long for his MD Anderson doctor, Ecaterina Dumbrave MD and her staff to love him like the rest of us. His determination became her determination.   Jim started the first clinical trial in June 2021.   With support from family, friends and the incredible team of doctors and healthcare staff at MD Anderson, Jim continues to fight the cancer with a positive attitude and determination.  I will keep this site updated with each of his treatments and scans.

Diagnosis … Prostate cancer metastasis to lymph nodes, cervical, thoracic and lumbar spine, hips, ribs, kidneys, right lung and liver.
June 2021 - Clinical Trial: PT-112 sponsored by Phosplatin Therapeutics
August 2021 - Clinical Trial:  Nivolumab with Ipilimumab
September 2021 - During this trial Jim experienced a great deal of pain in his back and hips.  Bone scan found he had compression fractures in his lower spine L2-L5.  He received 2 weeks of palliative radiation that relieved a great deal of the pain.  
November 2021 - Clinical Trial:  DS-7300A sponsored by Daiichi Sankyo
The first two trials were unsuccessful.  DS-7300A has had mixed results with some lymph nodes showing smaller in size but a new small spot on rib. During this trial his PSA has gone from 515 to 444 and that's exciting.  His doctor along with the research team feel this trial is keeping the cancer stable and will continue him on the trial until scans show differently. 
Next bone & CT scan scheduled for 2/16.  Next treatment scheduled for 2/18.
His doctor has a different trial waiting in the wings for him when it's needed.  Once DS-7300A is no longer effective, they will switch him to BPX-601.   I have provided more information on BPX-601 in a journal entry.